Farrell Thomas J.
Insider CIK 1626859 · BLCM President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 48,375 | — | $0 | 48,375 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 26,875 | — | $0 | 26,875 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2016-01-04 | 2016-01-06 | 160,000 | — | $0 | 160,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-10-01 | 2015-10-06 | 2,500 | $14.58 | $36.5K | 63,862 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-09-01 | 2015-09-03 | 2,500 | $16.78 | $42.0K | 66,362 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-08-03 | 2015-08-05 | 2,500 | $20.24 | $50.6K | 68,862 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2015-02-24 | 2015-02-26 | 160,000 | — | $0 | 160,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 21,622 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 7,568 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | J Other | 2014-12-23 | 2014-12-23 | 607 | — | $0 | 70,717 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 12,718 | — | $0 | 65,659 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 4,451 | — | $0 | 70,110 | SEC↗ |